By Cleaves M. Bennett, MD | Contributing Writer
- Vol. 8, No. 3. , 2007
The cholesterol model of heart disease, which labels LDL as “bad” and HDL as “good,” has certainly helped drug companies sell a lot of statin medications. But has it really reduced the impact of obesity, heart disease and diabetes in this country? “Not really,” says Dr. Cleaves Bennett, one of the nation’s leading experts on hypertension, kidney disease and preventive medicine.
The Content you are trying to see is available only for members of our site. If you already have a Membership you need to
log in to see it. Please follow this link if you want to
register.